Skip to content

Knee Aspiration and High Definition MRI for ACL Injury

Pilot Study Into the Structural Local Molecular Environment Following an ACL Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04901858
Enrollment
5
Registered
2021-05-26
Start date
2019-11-22
Completion date
2024-11-30
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury

Brief summary

The aim of this pilot study is to understand the biological changes that occur within the knee joint following injury to the anterior cruciate ligament (ACL). This will be achieved through aspiration and analysis of the haemarthrosis which fills the knee following injury. The study will look at inflammatory and healing responses using DNA, RNA and protein analysis. This, combined with high resolution imaging of the knee and surrounding soft tissue structures, may enable a more patient specific approach to treatment of ACL injury.

Interventions

DIAGNOSTIC_TESTAspiration of haemarthrosis and high definition MRI

Aspiration of haemarthrosis and high definition MRI

Sponsors

Cambridge University Hospitals NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of ACL injury confirmed by MRI * All participants must have the capacity to provide informed consent to participate * Participants must be able to comply with required study visit

Exclusion criteria

* Participants outside of the specified age range * Participants who do not have the mental capacity to make informed decisions * Participants who have meniscal pathology or other injuries requiring urgent surgery

Design outcomes

Primary

MeasureTime frameDescription
Pattern of injury on High Definition MRI measured by comparison with 3t MRI imagesLast visit, usually 28 daysOutcome will illustrate any additional benefit of high definition MRI

Secondary

MeasureTime frame
Identification of acute inflammatory mediators measured by NanoString molecular analysisLast visit, usually 28 days

Countries

United Kingdom

Contacts

Primary ContactStephen McDonnell
sm2089@cam.ac.uk01223 217551
Backup ContactJenny O'Callaghan
jennifer.ocallaghan@nihr.ac.uk01223 217551

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026